Showing results (61-70 of 693) with videos related to
Sort By:
Pageof 70
British Journal of Haematology|June 16, 2016
Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trialDai Chihara, Hagop Kantarjian, Susan O'Brien, et al.Leukemia & Lymphoma|August 10, 2013
Patient-driven discontinuation of tyrosine kinase inhibitors: single institution experienceOhad Benjamini, Hagop Kantarjian, Mary Beth Rios, et al.The Lancet. Haematology|December 22, 2015
Long-term molecular and cytogenetic response and survival outcomes with imatinib 400 mg, imatinib 800 mg, dasatinib, and nilotinib in patients with chronic-phase chronic myeloid leukaemia: retrospective analysis of patient data from five clinical trialsPreetesh Jain, Hagop Kantarjian, Mona Lisa Alattar, et al.Cancer|August 11, 2016
A propensity score matching analysis of dasatinib and nilotinib as a frontline therapy for patients with chronic myeloid leukemia in chronic phaseKoichi Takahashi, Hagop M Kantarjian, Yulong Yang, et al.Cancer|October 20, 2015
Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitorsKoji Sasaki, Hagop M Kantarjian, Preetesh Jain, et al.Leukemia & Lymphoma|September 6, 2013
Mutated NPM1 in patients with acute myeloid leukemia in remission and relapsePreetesh Jain, Hagop Kantarjian, Keyur Patel, et al.British Journal of Haematology|February 6, 2016
Analysis of 2013 European LeukaemiaNet (ELN) responses in chronic phase CML across four frontline TKI modalities and impact on clinical outcomesPreetesh Jain, Hagop Kantarjian, Koji Sasaki, et al.Oncotarget|March 22, 2021
STAT3 induces the expression of GLI1 in chronic lymphocytic leukemia cellsUri Rozovski, David M Harris, Ping Li, et al.British Journal of Haematology|May 23, 2018
Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL)Preetesh Jain, Jorge Romaguera, Samer A Srour, et al.Molecular Cancer Research : MCR|January 29, 2017
Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 ComplexUri Rozovski, David M Harris, Ping Li, et al.Pageof 70